A previous study also used the CIBERSORT algorithm for analysis to develop an immunescore prognostic model for immune-related genes associated with TP53 mutation status, and have validated their relationship with prognosis in CRC patients [20]. This evidence concerns the gene TP53 and colorectal carcinoma.